Connect with us

Health

Pfizer to submit emergence use approval request for Covid-19 vaccine again: Spokesperson – Deccan Herald

After reports of Pfizer withdrawing its application for emergency use authorisation of its Covid-19 vaccine in India, the company spokesperson said that it will resubmit…

Published

on

post featured image

Pfizer Inc said on Friday it had withdrawn an application for emergency-use authorisation of its Covid-19 vaccine in India, after failing to meet the drug regulator’s demand for a local safety and immunogenicity study.
The decision means the vaccine will not be available for sale in the world’s two most populous countries, India and China, in the near future. Both countries are running their immunisation campaigns using other products.
Unlike other companies conducting small studies in India for…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending